Genomics |
Genome-wide association study (GWAS) |
Observational study testing the association of genome-wide common genetic variation with a trait in a population of individuals. |
Reviewed in [6, 7] |
Whole-genome sequencing (WGS) |
Sequencing of the whole genome. Usually applied in the study of inherited disorders resulting in HF. |
[8, 9] |
Whole-exome sequencing (WES) |
Sequencing of the exome (protein-coding portion) of the genome. Usually used to study forms of HF with known genetic etiologies. |
Reviewed in [6] |
Transcriptomics |
Microarray |
Quantification of RNA by fluorescence measurement of cDNA using chips. Limited to genes targeted by array chip. |
[10, 11] |
Bulk RNAseq |
Quantification of RNA though sequencing of cDNA, alignment to reference genome, and counting. |
[12, 13] |
Single-cell RNAseq |
Single cell or nucleus isolation prior to RNAseq |
[14••] |
Spatial transcriptomics |
RNAseq performed on patches of tissue on slides |
[15] |
Proteomics |
The study of proteins or peptides in a targeted or agnostic manner. |
Reviewed in [16–18] |
Metabolomics |
The agnostic or targeted study of metabolites. |
Reviewed in [19] |
Lipidomics |
The study of the complete or targeted lipid profile in an individual or population |
[20, 21] |
Wearables |
An item worn externally that provides continuous data on parameters like heart rate, blood pressure, or fitness activity. |
Reviewed in [22] |
Clinical data |
Electronic health records |
Electronic data representing patients or patient groups produced for the purpose of managing clinical care |
[23] |
Imaging data |
The process of creating visual representation of physiology. Examples include CT, MRI, echocardiography, EKG, X-ray. |
Reviewed in [24] |